Preventing the cardiotoxicity of anthracyclines by dexrazoxane.
Hellmann
K
K
D000903:Antibiotics, Antineoplastic / Q000009:adverse effects*; D002614:Chelating Agents / Q000627:therapeutic use*; D006321:Heart / Q000187:drug effects; D006801:Humans; D011929:Razoxane / Q000627:therapeutic use*
D000903:Antibiotics, Antineoplastic; D002614:Chelating Agents; D011929:Razoxane